Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionShufro Rose & Co Llc
Latest Disclosed Ownership2,598 shares
Latest Disclosed Value $ 2,007,576
Shufro Rose & Co Llc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 15, 2026 - Shufro Rose & Co Llc filed a 13F-HR form disclosing ownership of 2,598 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $2,007,576 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,635 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -1.40% during the quarter.

Shufro Rose & Co Llc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,598 -37 -1.40 2,008 -49.36 0.1266
2026-02-09 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,635 12 0.46 3,964 138.30 0.2681
2025-11-12 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,623 0 0.00 1,664 0.00 0.1359
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,623 -2,655 -50.30 1,664 -48.97 0.1337
2025-05-08 2025-03-31 13F REGENERON PHARMACEUTICALS PUT 75886F107 5,278 2,592 96.50 3,260 83.09 0.2574
2025-02-25 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,686 2,393 816.72 1,913 523.13 0.1479
2024-11-12 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 293 0 0.00 308 0.00 0.0250
2024-08-13 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 293 0 0.00 308 8.87 0.0250
2024-05-08 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 293 0 0.00 282 17.01 0.0233
2024-02-05 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 293 0 0.00 241 0.00 0.0229
2023-10-26 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 293 -50 -14.58 241 -2.03 0.0227
2023-08-03 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 343 -100 -22.57 246 -32.42 0.0225
2023-04-20 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 443 0 0.00 364 14.11 0.0337
2023-01-25 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 443 0 0.00 320 4.59 0.0270
2022-10-24 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 443 0 0.00 305 16.41 0.0305
2022-07-22 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 443 -15 -3.28 262 -18.12 0.0227
2022-05-09 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 458 -388 -45.86 320 -40.07 0.0247
2022-01-27 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 846 12 1.44 534 5.74 0.0386
2021-11-05 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 834 0 0.00 505 8.37 0.0395
2021-07-28 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 834 4 0.48 466 18.58 0.0351
2021-04-28 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 830 0 0.00 393 -2.00 0.0312
2021-02-03 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 830 230 38.33 401 19.35 0.0336
2020-10-27 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 336 -10.16 0.0323
2020-08-06 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 374 27.65 0.0369
2020-04-22 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 293 30.22 0.0349
2020-01-28 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 600 600 225 0.0203
2019-07-24 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -600 -100.00 0 -100.00
2019-05-03 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 246 9.82 0.0246
2019-02-01 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 224 -7.44 0.0248
2018-10-26 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 0 0.00 242 16.91 0.0225
2018-07-27 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 -100 -14.29 207 -14.11 0.0198
2018-05-04 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 700 0 0.00 241 -8.37 0.0238
2018-02-05 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 700 100 16.67 263 -1.87 0.0259
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 600 268 0.0269
2016-11-09 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -600 -100.00 0 -100.00
2016-08-05 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 600 -2,737 -82.02 210 -82.54 0.0232
2016-05-26 2016-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 3,337 3,337 1,203 0.1344
2016-05-11 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,337 1,203
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-25 2024-12-31 13F REGENERON PHARMACEUTICALS CALL Call 285 n/a n/a n/a
2022-05-07 2022-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-01-27 2021-12-31 13F REGENERON PHARMACEUTICALS COM Call 500 316 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS PUT Put 1,932 21.83 n/a n/a n/a
2025-11-12 2025-09-30 13F REGENERON PHARMACEUTICALS PUT Put 1,586 0.00 n/a n/a n/a
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS PUT Put 1,586 -51.37 n/a n/a n/a
2025-05-08 2025-03-31 13F REGENERON PHARMACEUTICALS PUT 5,278 96.50 3,260 83.09 n/a n/a n/a
2025-02-25 2024-12-31 13F REGENERON PHARMACEUTICALS PUT Put 1,781 1,189.86 n/a n/a n/a
2022-10-24 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 138 n/a n/a n/a
2021-04-28 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-03 2020-12-31 13F REGENERON PHARMACEUTICALS COM Put 200 97 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.